Invitrogen, Luminex Extend and Expand License | GenomeWeb
NEW YORK, (GenomeWeb News) – Invitrogen and Luminex jointly announced today that they have extended and expanded a licensing agreement for Luminex’s multiplex technology and systems.
 
The new license extends the lifetime of the license and expands Invitrogen’s rights to include Luminex’s next-generation multiplex detection platforms. The firms did not disclose the length of or terms of the agreement.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.